Resolvin D1 giảm nhẹ phản ứng miễn dịch bẩm sinh ở mô hình chuột thí nghiệm chảy máu dưới nhện

van Gijn J, Kerr RS, Rinkel GJE (2007) Subarachnoid haemorrhage. Lancet 369(9558):306–318 Miller BA, Turan N, Chau M, Pradilla G (2014) Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int 2014:384342 Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4(4):432–446 Schneider UC, Xu R, Vajkoczy P (2018) Inflammatory Events Following Subarachnoid Hemorrhage (SAH). Curr Neuropharmacol 16(9):1385–1395 Ahn SH, Savarraj JPJ, Parsha K, Hergenroeder GW, Chang TR, Kim DH, Kitagawa RS, Blackburn SL et al (2019) Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage. J Neuroinflammation 16(1):213 Gris T, Laplante P, Thebault P, Cayrol R, Najjar A, Joannette-Pilon B, Brillant-Marquis F, Magro E et al (2019) Innate immunity activation in the early brain injury period following subarachnoid hemorrhage. J Neuroinflammation 16(1):253 Provencio JJ (2013) Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl 115:233–238 Buckley CD, Gilroy DW, Serhan CN (2014) Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40(3):315–327 Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R-L (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196(8):1025–1037 Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M (2012) Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 32(8):1970–1978 Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R et al (2012) Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol 189(4):1983–1991 Wang L, Yuan R, Yao C, Wu Q, Christelle M, Xie W, Zhang X, Sun W et al (2014) Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice. Chin Med J 127(5):803–809 Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510(7503):92–101 Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN (2012) Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 180(5):2018–2027 Bisicchia E, Sasso V, Catanzaro G, Leuti A, Besharat ZM, Chiacchiarini M, Molinari M, Ferretti E et al (2018) Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX/FPR2 receptor-regulated microRNAs. Mol Neurobiol 55(8):6894–6905 Rey C, Nadjar A, Buaud B, Vaysse C, Aubert A, Pallet V, Laye S, Joffre C (2016) Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Brain Behav Immun 55:249–259 Liu GJ, Tao T, Wang H, Zhou Y, Gao X, Gao YY, Hang CH, Li W (2020) Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury. J Neuroinflammation 17(1):239 Ye XH, Wu Y, Guo PP, Wang J, Yuan SY, Shang Y, Yao SL (2010) Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res 1323:174–183 Guo Z, Hu Q, Xu L, Guo ZN, Ou Y, He Y, Yin C, Sun X et al (2016) Lipoxin A4 reduces inflammation through formyl peptide receptor 2/p38 MAPK signaling pathway in subarachnoid hemorrhage rats. Stroke 47(2):490–497 Martini AC, Berta T, Forner S, Chen G, Bento AF, Ji RR, Rae GA (2016) Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. J Neuroinflammation 13(1):75 Migeotte I, Communi D, Parmentier M (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17(6):501–519 Chiang N, Takano T, Arita M, Watanabe S, Serhan CN (2003) A novel rat lipoxin A4 receptor that is conserved in structure and function. Br J Pharmacol 139(1):89–98 Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC et al (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 184(5):2611–2619 Corminboeuf O, Leroy X (2015) FPR2/ALXR agonists and the resolution of inflammation. J Med Chem 58(2):537–559 Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107(4):1660–1665 Sehba FA (2014) Rat endovascular perforation model. Transl Stroke Res 5(6):660–668 Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167(2):327–334 Ye ZN, Wu LY, Liu JP, Chen Q, Zhang XS, Lu Y, Zhou ML, Li W et al (2018) Inhibition of leukotriene B4 synthesis protects against early brain injury possibly via reducing the neutrophil-generated inflammatory response and oxidative stress after subarachnoid hemorrhage in rats. Behav Brain Res 339:19–27 Xie Y, Guo H, Wang L, Xu L, Zhang X, Yu L, Liu Q, Li Y et al (2017) Human albumin attenuates excessive innate immunity via inhibition of microglial Mincle/Syk signaling in subarachnoid hemorrhage. Brain Behav Immun 60:346–360 Keep RF, Hua Y, Xi G (2012) Brain water content. A misunderstood measurement? Transl Stroke Res 3(2):263–265 Zhou C, Xie G, Wang C, Zhang Z, Chen Q, Zhang L, Wu L, Wei Y et al (2015) Decreased progranulin levels in patients and rats with subarachnoid hemorrhage: a potential role in inhibiting inflammation by suppressing neutrophil recruitment. J Neuroinflammation 12:200 Zhang X, Wu Q, Lu Y, Wan J, Dai H, Zhou X, Lv S, Chen X et al (2018) Cerebroprotection by salvianolic acid B after experimental subarachnoid hemorrhage occurs via Nrf2- and SIRT1-dependent pathways. Free Radic Biol Med 124:504–516 Casili G, Campolo M, Paterniti I, Lanza M, Filippone A, Cuzzocrea S, Esposito E (2018) Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury. J Neurotrauma 35(13):1437–1451 Zhang XS, Li W, Wu Q, Wu LY, Ye ZN, Liu JP, Zhuang Z, Zhou ML et al (2016) Resveratrol attenuates acute inflammatory injury in experimental subarachnoid hemorrhage in rats via inhibition of TLR4 Pathway. Int J Mol Sci 17(8):1331 Pan LN, Zhu W, Li Y, Xu XL, Guo LJ, Lu Q, Wang J (2014) Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents. PLoS One 9(6):e99526 Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q et al (2017) Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. Neurobiol Dis 108:173–182 Sun Q, Wu W, Hu YC, Li H, Zhang D, Li S, Li W, Li WD et al (2014) Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro. J Neuroinflammation 11:106 Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97(1):14–37 Kooijman E, Nijboer CH, van Velthoven CT, Mol W, Dijkhuizen RM, Kesecioglu J, Heijnen CJ (2014) Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat. PLoS One 9(6):e90584 Friedrich V, Flores R, Muller A, Bi W, Peerschke EI, Sehba FA (2011) Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J Neuroinflammation 8:103 Ye ZN, Zhuang Z, Wu LY, Liu JP, Chen Q, Zhang XS, Zhou ML, Zhang ZH et al (2016) Expression and cell distribution of leukotriene B4 receptor 1 in the rat brain cortex after experimental subarachnoid hemorrhage. Brain Res 1652:127–134 Atangana E, Schneider UC, Blecharz K, Magrini S, Wagner J, Nieminen-Kelha M, Kremenetskaia I, Heppner FL et al (2017) Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH). Transl Stroke Res 8(2):144–156 Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL et al (2016) Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci 17(4):497 Recchiuti A (2013) Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins Other Lipid Mediat 107:64–76 Wang Q, Zheng X, Cheng Y, Zhang YL, Wen HX, Tao Z, Li H, Hao Y et al (2014) Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. J Immunol 192(8):3765–3777 Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H et al (2015) 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep 3(12):e12628 Rossi S, Di Filippo C, Gesualdo C, Potenza N, Russo A, Trotta MC, Zippo MV, Maisto R et al (2015) Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. Mediat Inflamm 2015:149381 Zhang T, Shu HH, Chang L, Ye F, Xu KQ, Huang WQ (2015) Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats. Int Immunopharmacol 28(1):322–327 Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, Bonventre JV (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177(9):5902–5911 Chen F, Fan XH, Wu YP, Zhu JL, Wang F, Bo LL, Li JB, Bao R et al (2014) Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. Eur J Clin Microbiol Infect Dis 33(3):457–464 Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW (2010) Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161(3):707–720 de Oliveira Manoel AL, Macdonald RL (2018) Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage. Front Neurol 9:292 Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M, Godson C (2010) FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J 24(11):4240–4249 Han X, Yao W, Liu Z, Li H, Zhang ZJ, Hei Z, Xia Z (2016) Lipoxin A4 preconditioning attenuates intestinal ischemia reperfusion injury through Keap1/Nrf2 pathway in a lipoxin A4 receptor independent manner. Oxidative Med Cell Longev 2016:9303606 Stenfeldt AL, Karlsson J, Wenneras C, Bylund J, Fu H, Dahlgren C (2007) Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30(6):224–229 Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JY, Ryu SH (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 173(1):607–614 Tristao FS, Rocha FA, Moreira AP, Cunha FQ, Rossi MA, Silva JS (2013) 5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection. Infect Immun 81(4):1256–1266 Wenceslau CF, McCarthy CG, Szasz T, Goulopoulou S, Webb RC (2015) Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome. Am J Physiol Heart Circ Physiol 308(7):H768–H777 Cowan C, Muraleedharan CK, O'Donnell JJ 3rd, Singh PK, Lum H, Kumar A, Xu S (2014) MicroRNA-146 inhibits thrombin-induced NF-kappaB activation and subsequent inflammatory responses in human retinal endothelial cells. Invest Ophthalmol Vis Sci 55(8):4944–4951 Alam MM, O'Neill LA (2011) MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 41(9):2482–2485 Xie Y-F, Shu R, Jiang S-Y, Liu D-L, Ni J, Zhang X-L (2013) MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm 10(1):20 Wang LL, Huang Y, Wang G, Chen SD (2012) The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target? Med Hypotheses 78(3):398–401 Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481–12486 Saba R, Sorensen DL, Booth SA (2014) MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol 5:578 Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 3(3):159–166 Quinn SR, O'Neill LA (2011) A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 23(7):421–425 Xu MX, Tan BC, Zhou W, Wei T, Lai WH, Tan JW, Dong JH (2013) Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. CNS Neurosci Ther 19(4):235–243 Zhu M, Wang X, Hjorth E, Colas RA, Schroeder L, Granholm AC, Serhan CN, Schultzberg M (2016) Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis. Mol Neurobiol 53(4):2733–2749 Kantarci A, Aytan N, Palaska I, Stephens D, Crabtree L, Benincasa C, Jenkins BG, Carreras I et al (2018) Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease. Exp Neurol 300:111–120 Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G et al (2019) Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nat Commun 10(1):3945 Cherpokova D, Jouvene CC, Libreros S, DeRoo EP, Chu L, de la Rosa X, Norris PC, Wagner DD et al (2019) Resolvin D4 attenuates the severity of pathological thrombosis in mice. Blood 134(17):1458–1468